Level Ventures

Quantum Source is a company based in Rehovot, Israel, focused on developing a photonic quantum architecture for scalable and practical quantum computing. It aims to create systems that can operate with millions of qubits while significantly reducing complexity, footprint, power consumption, and cost compared to existing technologies. The company's innovative design utilizes chip-based photon-atom gates to facilitate the efficient exchange of quantum information between photonic and atomic qubits. By providing versatile building blocks for quantum systems, Quantum Source is positioned to enhance capabilities across various industries, including medicine, security, climate simulations, and finance, enabling solutions to complex computational challenges.

Enveda Biosciences is a biotechnology company focused on drug discovery through the exploration of chemical diversity found in nature. Utilizing AI-powered tools, the company develops a robust database of chemical molecules derived from living organisms. Enveda's platform integrates machine learning, metabolomics, and robotics to analyze natural samples for their chemical structures and biological activities. This innovative approach allows for the efficient identification of potential new medicines, including antibiotics and hypotensives, without the need for isolating individual compounds or conducting extensive experiments. By harnessing nature's hidden chemistry, Enveda aims to accelerate the development of novel therapeutics for the healthcare industry.

Enveda Biosciences is a biotechnology company focused on drug discovery through the exploration of chemical diversity found in nature. Utilizing AI-powered tools, the company develops a robust database of chemical molecules derived from living organisms. Enveda's platform integrates machine learning, metabolomics, and robotics to analyze natural samples for their chemical structures and biological activities. This innovative approach allows for the efficient identification of potential new medicines, including antibiotics and hypotensives, without the need for isolating individual compounds or conducting extensive experiments. By harnessing nature's hidden chemistry, Enveda aims to accelerate the development of novel therapeutics for the healthcare industry.

Perceptive Automata, Inc. specializes in developing machine learning and computer vision solutions focused on human behavior prediction for automated vehicles. Founded in 2014 and based in Somerville, Massachusetts, the company addresses critical challenges in the safe deployment of highly automated and fully autonomous vehicles, particularly in urban settings. Its technology enables these vehicles to anticipate the actions of pedestrians, cyclists, and other drivers, allowing for safe navigation in human-dominated environments. By employing advanced AI inference models, Perceptive Automata enhances the driving experience, facilitating smoother and more natural interactions between autonomous vehicles and their surroundings. The company collaborates with original equipment manufacturers (OEMs), suppliers, and technology firms in the development of advanced driver-assistance systems (ADAS) and autonomous driving technologies, leveraging expertise from leading institutions such as Harvard, MIT, and Stanford.

Artivest operates an online investment platform that connects individual investors and financial advisors with opportunities in private equity and hedge funds, which are typically accessible only to institutional investors. By leveraging technological, financial, and operational expertise, Artivest offers a seamless investment experience while ensuring high security through advanced encryption technology. This platform allows a broader audience to participate in top-quality investment opportunities, thus democratizing access to private investments and enhancing the scalability for fund managers.